| Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ... The Lancet Neurology 9 (1), 77-93, 2010 | 2408 | 2010 |
| Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ... The Lancet Neurology 9 (2), 177-189, 2010 | 1389 | 2010 |
| Profiles of neuromuscular diseases: Duchenne muscular dystrophy CM McDonald, RT Abresch, GT Carter, WM Fowler Jr, ER Johnson, ... American journal of physical medicine & rehabilitation 74 (5), S93, 1995 | 642 | 1995 |
| Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies LE Warner, P Mancias, IJ Butler, CM McDonald, L Keppen, KG Koob, ... Nature genetics 18 (4), 382-384, 1998 | 594 | 1998 |
| Ataluren treatment of patients with nonsense mutation dystrophinopathy K Bushby, R Finkel, B Wong, R Barohn, C Campbell, GP Comi, ... Muscle & nerve 50 (4), 477-487, 2014 | 502 | 2014 |
| The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy CM McDonald, EK Henricson, JJ Han, RT Abresch, A Nicorici, GL Elfring, ... Muscle & Nerve: Official Journal of the American Association of …, 2010 | 466 | 2010 |
| Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial CM McDonald, C Campbell, RE Torricelli, RS Finkel, KM Flanigan, ... The Lancet 390 (10101), 1489-1498, 2017 | 445 | 2017 |
| Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee … RT Moxley III, S Ashwal, S Pandya, A Connolly, J Florence, K Mathews, ... Neurology 64 (1), 13-20, 2005 | 421 | 2005 |
| Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study CM McDonald, EK Henricson, RT Abresch, T Duong, NC Joyce, F Hu, ... The Lancet 391 (10119), 451-461, 2018 | 410 | 2018 |
| Ultrasonographic evaluation of diaphragmatic motion. EO Gerscovich, M Cronan, JP McGahan, K Jain, CD Jones, C McDonald Journal of ultrasound in medicine 20 (6), 597-604, 2001 | 354 | 2001 |
| Natural history of infantile‐onset spinal muscular atrophy SJ Kolb, CS Coffey, JW Yankey, K Krosschell, WD Arnold, SB Rutkove, ... Annals of neurology 82 (6), 883-891, 2017 | 338 | 2017 |
| The 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study CM Mcdonald, EK Henricson, RT Abresch, JM Florence, M Eagle, ... Muscle & nerve 48 (3), 343-356, 2013 | 325 | 2013 |
| Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial JR Petrie, N Chaturvedi, I Ford, MCGJ Brouwers, N Greenlaw, T Tillin, ... The lancet Diabetes & endocrinology 5 (8), 597-609, 2017 | 321 | 2017 |
| The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a … CM McDonald, EK Henricson, RT Abresch, J Florence, M Eagle, ... Muscle & nerve 48 (3), 357-368, 2013 | 310 | 2013 |
| Physical activity, health impairments, and disability in neuromuscular disease CM McDonald American journal of physical medicine & rehabilitation 81 (11), S108-S120, 2002 | 304 | 2002 |
| Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy Y Hathout, E Brody, PR Clemens, L Cripe, RK DeLisle, P Furlong, ... Proceedings of the National Academy of Sciences 112 (23), 7153-7158, 2015 | 278 | 2015 |
| LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy KM Flanigan, E Ceco, KM Lamar, Y Kaminoh, DM Dunn, JR Mendell, ... Annals of neurology 73 (4), 481-488, 2013 | 241 | 2013 |
| SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy E Pegoraro, EP Hoffman, L Piva, BF Gavassini, S Cagnin, M Ermani, ... Neurology 76 (3), 219-226, 2011 | 241 | 2011 |
| The 6‐minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations CM MCDonald, EK Henricson, JJ Han, RT Abresch, A Nicorici, L Atkinson, ... Muscle & nerve 42 (6), 966-974, 2010 | 235 | 2010 |
| Development of the P erformance of the U pper L imb module for D uchenne muscular dystrophy A Mayhew, ES Mazzone, M Eagle, T Duong, M Ash, V Decostre, ... Developmental Medicine & Child Neurology 55 (11), 1038-1045, 2013 | 224 | 2013 |
